making it possible for patients and their families to travel and take HFCWO therapy along. Electromed also pioneered the first programmable and first multi-positional HFCWO generator.

Known as the “Innovation Leader in Airway Clearance,” Electromed holds 23 U.S. patents, 12 foreign patents, and has more than 25 U.S. and foreign patent applications pending. These innovations mean their SmartVest® Airway Clearance System is uniquely designed for ergonomic comfort and lifestyle convenience to promote consistent therapy adherence, so patients are more likely to gain maximum therapeutic benefit.